Utilization of the insulin-signaling network in the metabolic actions of α-lipoic acid - Reduction or oxidation?

Antioxidants and Redox Signaling

Volumn 7, Issue 7-8, 2005, Pages 1032-1039

  Konrad, Daniel ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUCOSE TRANSPORTER 4; GLUTATHIONE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE PHOSPHATASE 1B; PYRUVATE DEHYDROGENASE; THIOCTIC ACID;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; GLUCOSE; HUMANS; INSULIN; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; THIOCTIC ACID;

EID: 22044446353     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1032     Document Type: Review

References (73)

1. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA. and Tamborlane WY. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315: 215-219, 1986.
2. Avogaro A, Toffolo G, Miola M, Valerio A, Tiengo A, Cobelli C, and Del Prato S. Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest 98: 108-115, 1996.
3. Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, and Farese RV. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 138: 4721-4731, 1997.
4. Bandyopadhyay G, Standaert ML, Zhao L, Yu B, Avignon A, Galloway L, Karnam P, Moscat J, and Farese RV. Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J Biol Chem 272: 2551-2558, 1997.
5. Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB, and Chock PB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38: 6699-6705, 1999.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
7. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, and Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731, 2001.
8. Cho KJ, Moini H, Shon HK, Chung AS, and Packer L. Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes. Biochem Pharmacol 66: 849-858, 2003.
9. Cushman SW and Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 255: 4758-4762, 1980.
10. DeFronzo RA, Hendler R, and Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795-801, 1982.
11. Denu JM and Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 5633-5642, 1998.
12. Dicter N, Madar Z, and Tirosh O. Alpha-lipoic acid inhibits glycogen synthesis in rat soleus muscle via its oxidative activity and the uncoupling of mitochondria. J Nutr 132: 3001-3006, 2002.
13. Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, and Klip A. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 45: 1798-1804, 1996.
14. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002.
15. 2 in tumor necrosis factor alpha-mediated insulin resistance. J Biol Chem 274: 25078-25084, 1999.
16. Henriksen EJ, Jacob S, Streeper RS, Fogt DL, Hokama JY, and Tritschler HJ. Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life Sci 61: 805-812, 1997.
17. Henry RR, Thorburn AW, Beerdsen P, and Gumbiner B. Dose-response characteristics of impaired glucose oxidation in non-insulin-dependent diabetes mellitus. Am J Physiol 261: E132-E140, 1991.
18. Huang B, Wu P, Bowker-Kinley MM, and Harris RA. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes 51: 276-283, 2002.
19. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, and Dietze GJ. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45: 872-874, 1995.
20. Jacob S, Henriksen EJ, Tritschler HJ, Augustin HJ, and Dietze GJ. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 104: 284-288, 1996.
21. Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GJ, and Henriksen EJ. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45: 1024-1029, 1996.
22. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, and Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radice Biol Med 27: 309-314, 1999.
23. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, and Czech MP. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci U S A 100: 7569-7574, 2003.
24. Jordan SW and Cronan JE Jr. Biosynthesis of lipoic acid and posttranslational modification with lipoic acid in Escherichia coli. Methods Enzymol 279: 176-183, 1997.
25. Kaburagi Y, Yamamoto-Honda R, Tobe K, Ueki K, Yachi M, Akanuma Y, Stephens RM, Kaplan D, Yazaki Y, and Kadowaki T. The role of the NPXY motif in the insulin receptor in tyrosine phosphorylation of insulin receptor substrate-1 and Shc. Endocrinology 136: 3437-3443, 1995.
26. Kagan VE, Shvedova A, Serbinova E, Khan S, Swanson C, Powell R, and Packer L. Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 44: 1637-1649, 1992.
27. Kandror KV. A long search for Glut4 activation. Sci STKE 2003: PE5, 2003.
28. Katome T, Obata T, Matsushima R, Masuyama N, Cantley LC, Gotoh Y, Kishi K, Shiota H, and Ebina Y. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem 278: 28312-28323, 2003.
29. Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, Tritschler H, Wessel K, and Bashan N. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism 46: 763-768, 1997.
30. Khamaisi M, Rudich A, Potashnik R, Tritschler HJ, Gutman A, and Bashan N. Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats. Metabolism 48: 504-510, 1999.
31. Khanna S, Roy S, Packer L, and Sen CK. Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of alpha-lipoic acid. Am J Physiol 276: R1327-R1333, 1999.
32. Klip A, Ramlal T, Young DA, and Holloszy JO. Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224: 224-230, 1987.
33. Klip A, Volchuk A, Ramlal T, Ackerley C, and Mitsumoto Y. Glucose transporters of muscle cells in culture: developmental regulation and modulation by lipoic acid, an anti-hyperglycemic agent. Mol Biol Diabetes 511-528, 1994.
34. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, and Klip A. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50: 1464-1471, 2001.
35. Konrad D, Bilan PJ, Nawaz Z, Sweeney G, Niu W, Liu Z, Antonescu CN, Rudich A, and Klip A. Need for GLUT4 activation to reach maximum effect of insulin-mediated glucose uptake in brown adipocytes isolated from GLUT4myc-expressing mice. Diabetes 51: 2719-2726, 2002.
36. Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, and Usadel KH. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 22: 280-287, 1999.
37. Kotani K, Ogawa W, Matsumoto M, Kitamura T, Sakaue H, Hino Y, Miyake K, Sano W, Akimoto K, Ohno S, and Kasuga M. Requirement of atypical protein kinase Clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol 18: 6971-6982, 1998.
38. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
39. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, and Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes 50: 404-410, 2001.
40. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, and Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669, 2001.
41. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
42. Moini H, Tirosh O, Park YC, Cho KJ, and Packer L. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch Biochem Biophys 397: 384-391, 2002.
43. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, and Betteridge DJ. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40: 647-653, 1997.
44. Packer L, Witt EH, and Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995.
45. Packer L, Kraemer K, and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17: 888-895, 2001.
46. Paolisso G, D'Amore A, Di Maro G, Galzerano D, Tesauro P, Varricchio M, and D'Onofrio F. Evidence for a relationship between free radicals and insulin action in the elderly. Metabolism 42: 659-663, 1993.
47. Peth JA, Kinnick TR, Youngblood EB, Tritschler HJ, and Henriksen EJ. Effects of a unique conjugate of alpha-lipoic acid and gamma-linolenic acid on insulin action in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 278: R453-R459, 2000.
48. Pick U, Haramaki N, Constantinescu A, Handelman GJ, Tritschler HJ, and Packer L. Glutathione reductase and lipoamide dehydrogenase have opposite stereospecificities for alpha-lipoic acid enantiomers. Biochem Biophys Res Commun 206: 724-730, 1995.
49. Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Moller W, Tritschler HJ, and Mehnert H. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 31: 171-179, 1999.
50. Rudich A and Bashan N. Cellular redox state and insulin sensitivity: potential role of lipoic acid. In: Muscle Metabolism, edited by Zierath JR and Wallberg-Henriksen H. London, UK: Taylor and Francis, 2002, pp. 329-348.
51. Rudich A, Kozlovsky N, Potashnik R, and Bashan N. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol 272: E935-E940, 1997.
52. Rudich A, Tirosh A, Potashnik R, Khamaisi M, and Bashan N. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia 42: 949-957, 1999.
53. Sano H, Kane S, Sano E, Miinea CR. Asara JM, Lane WS, Garner CW, and Lienhard GE. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 278: 14599-14602, 2003.
54. Schmid E, El Benna J, Galter D, Klein G, and Droge W. Redox priming of the insulin receptor beta-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J 12: 863-870, 1998.
55. Schupke H, Hempel R, Peter G, Hermann R, Wessel K, Engel J, and Kronbach T. New metabolic pathways of alpha-lipoic acid. Drug Metab Dispos 29: 855-862, 2001.
56. Somwar R, Koterski S, Sweeney G, Sciotti R, Djuric S, Berg C, Trevillyan J, Scherer PE, Rondinone CM, and Klip A. A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation. J Biol Chem 111: 50386-50395, 2002.
57. Stacpoole PW and Greene YJ. Dichloroacetate. Diabetes Care 15: 785-791, 1992.
58. Streeper RS, Henriksen EJ, Jacob S, Hokama JY, Fogt DL, and Tritschler HJ. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am J Physiol 273: E185-E191, 1997.
59. Suzuki K and Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A 77: 2542-2545, 1980.
60. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, and Klip A. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274: 10071-10078, 1999.
61. Virkamaki A, Ueki K, and Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103: 931-943, 1999.
62. Wada H, Shintani D, and Ohlrogge J. Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production. Proc Natl Acad Sci U S A 94: 1591-1596, 1997.
63. Walgren JL, Amani Z, McMillan JM, Locher M, and Buse MG. Effect of R(+)alpha-lipoic acid on pyruvate metabolism and fatty acid oxidation in rat hepatocytes. Metabolism 53: 165-173, 2004.
64. Wang Q, Somwar R, Bilan PJ, Lm Z, Jin J, Woodgett JR, and Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 19: 4008-4018, 1999.
65. White MF. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182: 3-11, 1998.
66. Williamson JR, Browning ET, and Scholz R. Control mechanisms of gluconeogenesis and ketogenesis. I. Effects of oleate on gluconeogenesis in perfused rat liver. J Biol Chem 244: 4607-4616, 1969.
67. Wiznitzer A, Ayalon N, Hershkovitz R, Khamaisi M, Reece EA, Trischler H, and Bashan N. Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol 180: 188-193, 1999.
68. Wolf G, Trub T, Ottinger E, Groninga L, Lynch A, White MF, Miyazaki M, Lee J, and Shoelson SE. PTB domains of IRS-1 and She have distinct but overlapping binding specificities. J Biol Chem 270: 27407-27410, 1995.
69. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, and Harris RA. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48: 1593-1599, 1999.
70. Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, and Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43: 294-303, 2000.
71. Yki-Jarvinen H and Koivisto VA. Natural course of insulin resistance in type I diabetes. N Engl J Med 315: 224-230, 1986.
72. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schutte K, and Gries FA. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38: 1425-1433, 1995.
73. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, Kerum G, and Malessa R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 22: 1296-1301, 1999.